Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- PRCH +22.8%, IOT +15.2%, HCI +9.9%, SWBI +9.7%, DOCU +9.2%, FNKO +8.9% (also CFO/ COO Steve Nave to resign; names new CFO; COO position to remain unfilled), GPS +7.9%, GRND +7.9%, SNPO +5.1%, LOCO +3.6%, TGB +3%, TSM +2.9% (Feb revs), AQN +2%, GWRE +1.2%
Other news:
- DAWN +16% (amended Viracta License Agreement)
- KYTX +4.2% (Kyverna Therapeutics and Stanford University Agree to Evaluate KYV-101 in Patients with Non-Relapsing and Progressive Forms of Multiple Sclerosis)
- LCTX +3.5% (files $200 mln mixed shelf securities offering)
- ATHA +2.9% (presents clinical and preclinical data supporting therapeutic potential of fosgonimeton in alzheimer's and parkinson's diseases at AD/PD 2024 International Conference)
- SPRY +1.7% (reviews recent clinical updates and commercial opportunity)
- ML +1.1% (files $50 mln mixed shelf securities offering)
- LDOS +1% (awarded $158 mln US Air Force contract)
Analyst comments:
- CVNA +5.8% (upgraded to Sector Perform from Underperform at RBC Capital Mkts)
- GE +1% (upgraded to Overweight from Neutral at JP Morgan)